Assessment of Trends in Guideline-Based Oral Anticoagulant Prescription for Patients With Ischemic Stroke and Atrial Fibrillation in China

Authors:

Abstract
Atrial fibrillation (AF) is a known cardiac risk factor for ischemic stroke.1-3 Findings from contemporary registry-based observational studies from various geographical regions have consistently shown that patients with ischemic stroke and AF have worse prognoses, higher rates of medical and neurologic complications, and higher case fatality rates than those without AF.4-7 Nevertheless, stroke associated with AF is mostly preventable, and the use of oral anticoagulants (OACs), including warfarin and non–vitamin K oral anticoagulants (NOACs), was associated with effectively reducing ischemic stroke and systemic thromboembolism in high-risk patients with AF.8-10 However, the prescribing of OACs has not been well characterized for patients in China with ischemic stroke and AF, as previous studies have been limited in terms of sample size, geographical regions studied, or types of OACs prescribed.11-14

This publication has 31 references indexed in Scilit: